[Pembrolizumab+chemotherapy as first-line treatment in patients with HER2 negative advanced oesogastric adenocarcinoma].

Bull Cancer

Département d'oncologie digestive, hôpital européen Georges-Pompidou (HEGP), Assistance publique-Hôpitaux de Paris (AP-HP), université Paris Cité, institut du cancer parisien CARPEM, 20, rue Leblanc 75015 Paris, France.

Published: May 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2024.01.004DOI Listing

Publication Analysis

Top Keywords

[pembrolizumab+chemotherapy first-line
4
first-line treatment
4
treatment patients
4
patients her2
4
her2 negative
4
negative advanced
4
advanced oesogastric
4
oesogastric adenocarcinoma]
4
[pembrolizumab+chemotherapy
1
treatment
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!